ZA909384B - Delayed release formulations - Google Patents

Delayed release formulations

Info

Publication number
ZA909384B
ZA909384B ZA909384A ZA909384A ZA909384B ZA 909384 B ZA909384 B ZA 909384B ZA 909384 A ZA909384 A ZA 909384A ZA 909384 A ZA909384 A ZA 909384A ZA 909384 B ZA909384 B ZA 909384B
Authority
ZA
South Africa
Prior art keywords
pct
delayed release
sec
release formulations
date
Prior art date
Application number
ZA909384A
Other languages
English (en)
Inventor
Stephen Gordon Ring
Gordon Ring Stephen
David Brian Archer
Brian Archer David
Michael Charles Allwood
Charles Allwood Michael
John Michael Newton
Michael Newton John
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA909384B publication Critical patent/ZA909384B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Die Bonding (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Paints Or Removers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA909384A 1989-11-24 1990-11-22 Delayed release formulations ZA909384B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898926639A GB8926639D0 (en) 1989-11-24 1989-11-24 Delayed release formulations

Publications (1)

Publication Number Publication Date
ZA909384B true ZA909384B (en) 1992-07-29

Family

ID=10666886

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909384A ZA909384B (en) 1989-11-24 1990-11-22 Delayed release formulations

Country Status (17)

Country Link
US (1) US5294448A (de)
EP (1) EP0502032B1 (de)
JP (1) JP2975680B2 (de)
KR (1) KR920703030A (de)
AT (1) ATE103174T1 (de)
CA (1) CA2069485C (de)
DE (1) DE69007623T2 (de)
DK (1) DK0502032T3 (de)
ES (1) ES2053206T3 (de)
FI (1) FI103091B1 (de)
GB (2) GB8926639D0 (de)
HU (1) HU209243B (de)
NO (1) NO303424B1 (de)
NZ (1) NZ236188A (de)
RU (1) RU2093148C1 (de)
WO (1) WO1991007949A1 (de)
ZA (1) ZA909384B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
DE4120918A1 (de) * 1991-06-25 1993-01-07 Basf Ag Pulverfoermige praeparate aus einer wasserunloeslichen kernsubstanz und einer schutzhuelle
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
DE69229710T2 (de) * 1991-11-15 2000-03-02 Kanegafuchi Kagaku Kogyo K.K., Osaka Esterbindung enthaltende Polymere für pharmazeutische Zubereitungen
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5565407A (en) * 1993-12-27 1996-10-15 University Of Kansas Center For Research, Inc. Biologically active agent encapsulated in biodegradable starch/polymer matrices
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
KR100542544B1 (ko) * 1995-12-21 2006-05-10 파마슈티스크 라보라토리움 페링 에이/에스 5-아미노살리실산을함유하는방출제어형경구용약제학적조성물및장질환을치료하는방법
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) * 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
RU2153340C1 (ru) * 1999-12-14 2000-07-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтический состав, регулирующий метаболические процессы, и способ его получения
US8101200B2 (en) 2000-04-13 2012-01-24 Angiotech Biocoatings, Inc. Targeted therapeutic agent release devices and methods of making and using the same
RU2191782C2 (ru) * 2000-09-21 2002-10-27 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения модифицированной гиалуроновой кислоты
RU2259817C2 (ru) * 2000-10-13 2005-09-10 Кембридж Байостэбилити Лтд. Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
EA008224B1 (ru) * 2001-03-13 2007-04-27 Пенвест Фармасьютикалз Ко. Хронотерапевтические дозированные формы
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
CA2461708C (en) * 2001-09-28 2012-08-07 Nutraceutix, Inc. Delivery system for biological component
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
KR20050044545A (ko) * 2001-11-21 2005-05-12 에자이 가부시키가이샤 산에 불안정한 생리활성 화합물을 함유하는 제제 조성물및 그 제법
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
CN1726012A (zh) * 2002-12-11 2006-01-25 辉瑞产品公司 活性物质在高脂肪环境中的控制释放
EA200600598A1 (ru) * 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
BRPI0514827A (pt) * 2004-09-01 2008-06-24 Procter & Gamble composições compreendendo ácido 5-amino-2hidróxi- benzóico e açúcar redutor
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
RU2322242C2 (ru) * 2006-05-03 2008-04-20 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Способ эндоскопического лечения эрозивно-язвенных поражений слизистой желудка и двенадцатиперстной кишки у ангио-кардиохирургических больных
EP2061440A2 (de) 2007-04-04 2009-05-27 Sigmoid Pharma Limited Pharmazeutische tacrolimus-zusammensetzung
TWI422398B (zh) * 2007-06-04 2014-01-11 Univ London 結腸給藥配方
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
WO2010040113A1 (en) 2008-10-03 2010-04-08 Salix Pharmaceuticals, Ltd. Compositions and methods for the treatment of bowel diseases with granulated mesalamine
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
ES2520165T3 (es) 2009-01-14 2014-11-11 Novacta Biosystems Limited Derivados de desoxiactagardina
WO2010089544A1 (en) 2009-02-04 2010-08-12 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
EP2386297A1 (de) * 2010-04-28 2011-11-16 Roquette Frères Unverdauliches Polymer: Filmüberzüge auf Basis von acetylierter Stärke für Colon-Targeting
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
ES2586931T3 (es) 2010-11-04 2016-10-19 Albireo Ab Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
ES2655622T3 (es) 2012-04-30 2018-02-20 Tillotts Pharma Ag Una formulación de fármaco de liberación retardada
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
AU2013404367B2 (en) 2013-10-29 2020-02-27 Tillotts Pharma Ag A delayed release drug formulation
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
DE102015000795A1 (de) * 2015-01-23 2016-07-28 Se Tylose Gmbh & Co. Kg Reversibel vernetzte Celluloseether und Verfahren zu deren Herstellung durch selektive Oxidation von vicinalen OH-Gruppen
EP3413877B1 (de) 2016-02-09 2021-04-07 Albireo AB Orale cholestyraminformulierungen und verwendung davon
EP3413878B1 (de) * 2016-02-09 2021-04-14 Albireo AB Orale cholestyraminformulierungen und verwendung davon
EP3413875B1 (de) 2016-02-09 2020-01-29 Albireo AB Cholestyraminpellets und verfahren zur herstellung davon
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
EP3662902B1 (de) 2018-12-07 2024-07-31 Tillotts Pharma AG Formulierung mit freisetzung eines wirkstoffs im kolon
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
EP3662901B1 (de) 2018-12-07 2025-01-01 Tillotts Pharma AG Arzeimittelformulierumg mit verzögerter freisetzung mit einer aussenschicht enthaltend ein enzymatisch abbaubares polymer, ihre zusammensetzung und ihr herstellungsverfahren
WO2022254456A1 (en) * 2021-06-01 2022-12-08 Nbi Biosciences Pvt Ltd Microbial-triggered oral intestinal drug delivery formulation and method of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086627B1 (de) * 1982-02-12 1985-08-28 Unitika Ltd. Antikrebsmittel
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4911952A (en) * 1987-07-10 1990-03-27 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment within matrix of unmodified starch
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
CA2069485C (en) 2000-04-18
HU209243B (en) 1994-04-28
FI103091B (fi) 1999-04-30
US5294448A (en) 1994-03-15
GB2238243A (en) 1991-05-29
NZ236188A (en) 1992-11-25
DE69007623D1 (de) 1994-04-28
WO1991007949A1 (en) 1991-06-13
FI103091B1 (fi) 1999-04-30
EP0502032A1 (de) 1992-09-09
GB8926639D0 (en) 1990-01-17
DE69007623T2 (de) 1994-06-30
NO303424B1 (no) 1998-07-13
NO922026D0 (no) 1992-05-22
DK0502032T3 (da) 1994-05-09
NO922026L (no) 1992-07-23
HU9201719D0 (en) 1992-08-28
GB2238243B (en) 1993-09-08
ES2053206T3 (es) 1994-07-16
KR920703030A (ko) 1992-12-17
HUT62463A (en) 1993-05-28
RU2093148C1 (ru) 1997-10-20
FI922369A0 (fi) 1992-05-22
ATE103174T1 (de) 1994-04-15
GB9025373D0 (en) 1991-01-09
JPH05504947A (ja) 1993-07-29
FI922369L (fi) 1992-05-22
JP2975680B2 (ja) 1999-11-10
EP0502032B1 (de) 1994-03-23

Similar Documents

Publication Publication Date Title
GB2238243B (en) Delayed release formulations
GB2220350B (en) Delayed release formulations
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
MY112915A (en) Multiple unit tableted dosage form 1
TW285667B (de)
GR3033827T3 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
CA2009735A1 (en) Insecticidally active nitro compounds
IL115046A0 (en) A sprayable film-forming preparation for application to plants and the uses thereof
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
AU7827191A (en) Sprayable fireproofing composition
MY107431A (en) Insecticidal n''''substituted-n-alkylcarbonyl-n''''-acylhydra zines and n''''substituted-n-acyl-n''''-alkylcarbonylhydrazines.
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
AU665397B2 (en) Fungicidal compositions
AU1067295A (en) Substituted aminoalkylaminopyridines
MD1165F2 (en) The coated pesticidal agents, processes for their preparation and compositions containing them
GR3021761T3 (en) Leukotriene-b 4? derivatives, process for preparing the same and medicaments.
EP0305194A3 (de) Tierärztliche Zusammensetzung